This study investigates the use of an investigational ultrasound-guided therapy for patients with unresectable pancreatic ductal adenocarcinoma. The purpose of this study is to explore if this therapy can be a feasible option for treating this condition.
The study focuses on evaluating the safety, tolerability, and overall performance of the therapy. It will look into how well the therapy works and any technical successes in using it.
- Who can participate: Participants must be 22 years or older with a diagnosis of pancreatic ductal adenocarcinoma that is unresectable. They should have a measurable tumor and good organ function.
- Study details: Participants will undergo ultrasound-guided therapy sessions.
- Study timelines: The study will last up to 3.5 months with additional long-term follow-up until death or up to 5 years.
How understandable was the trial content above?
Hard to understand
Easy to understand